Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System
Condition(s):Prostate CancerLast Updated:November 29, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:November 29, 2023Recruiting
Condition(s):Prostatic Neoplasms; Hypogonadism; Testosterone DeficiencyLast Updated:March 15, 2024Recruiting
Condition(s):Neoplasms of the ProstateLast Updated:May 18, 2023Active, not recruiting
Condition(s):Malignant Neoplasm of ProstateLast Updated:December 18, 2023Suspended
Condition(s):Prostate Cancer; IncontinenceLast Updated:June 11, 2021Completed
Condition(s):Prostatic Neoplasms, ProstatectomyLast Updated:September 28, 2010Unknown status
Condition(s):Prostatic NeoplasmsLast Updated:March 4, 2008Completed
Condition(s):Urinary Incontinence; Prostate CancerLast Updated:December 29, 2014Completed
Condition(s):Prostate Cancer; Advanced Renal Cell Carcinoma; Advanced Urothelial Carcinoma; Genitourinary CancerLast Updated:July 21, 2023Active, not recruiting
Condition(s):Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate CancerLast Updated:February 13, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.